Our Portfolio Optimization solutions in the Asia-Pacific region help customers assess current and future product potential, enabling them to allocate resources across their portfolios to maximize performance. 

Our pharmaceutical audits in Japan and Korea, for example, document national sales data for all prescription products, including information on sales values, sales units, market share and growth rates.  Separate hospital pharmaceutical audits in Japan and in the cities of Beijing, Shanghai and Guangzhou, China, track sales data and the use of prescription drugs by manufacturer and product.  Medical data surveys of Shanghai doctors, and of doctors at hospitals with more than 100 beds throughout Japan, track prescription and diagnosis data.

A comprehensive survey of all prescription drugs and over-the-counter healthcare products supplied to retail pharmacies is provided in the Australia Pharmaceutical Index.  Data is sourced from pharmaceutical wholesalers and subscribing manufacturers who sell products directly to retail pharmacies. 

IMS audits, offered at national, sub-national and even city levels, give our customers the information they need to drive brand success and quickly respond to marketplace changes.  We are aggressively expanding medical audit services in several Asia-Pacific countries, providing the facts, interpretations and guidance needed for targeted decisions and portfolio optimization in specific markets.

	To learn more about how IMS can help your company, contact us. For regional contact information, click here.

email this page     print this page